The OspF family of phosphothreonine lyase, including SpvC from Salmonella, irreversibly inactivates the dual-phosphorylated host MAPKs (pT-X-pY) through b elimination. We determined crystal structures of SpvC and its complex with a phosphopeptide substrate. SpvC adopts a unique fold of a/b type. The disordered N terminus harbors a canonical D motif for MAPK substrate docking. The enzyme-substrate complex structure indicates that recognition of the phosphotyrosine followed by insertion of the threonine phosphate into an arginine pocket places the phosphothreonine into the enzyme active site. This requires the conformational flexibility of pT-X-pY, which suggests that p38 (pT-GpY) is likely the preferred physiological substrate. Structure-based biochemical and enzymatic analysis allows us to propose a general acid/base mechanism for b elimination reaction catalyzed by the phosphothreonine lyase. The mechanism described here provides a structural understanding of MAPK inactivation by a family of pathogenic effectors conserved in plant and animal systems and may also open a new route for biological catalysis.
INTRODUCTION
Many Gram-negative bacterial pathogens have evolved a specialized type III secretion system (TTSS) to deliver effector proteins into their cognate host cells (Galan and Wolf-Watz, 2006) . These effectors are usually potent modulators of host cellular processes essential for counteracting bacteria infection. Mitogen-activated protein kinase (MAPK) pathways play important roles in activating host innate immune responses (Dong et al., 2002) and are frequent targets of pathogenic effectors in both plant and animal systems (Shan et al., 2007) . For instance, the Yersinia TTSS effector YopJ acetylates the host MAPK kinases and prevents them from phosphorylation and activation (Mukherjee et al., 2006) . All MAPKs, including extracellular signal-regulated protein kinases (Erk), c-Jun N-terminal kinases (JNK), and p38, the three major families in mammals, are activated by dual phosphorylation of the conserved T-X-Y motif in the activation loop (Dong et al., 2002) . We and others have recently identified a family of conserved TTSS effectors that includes OspF from Shigella spp., SpvC from nontyphoid Salmonella species, and HopAI1 from plant pathogen Pseudomonas syringae (Arbibe et al., 2007; Kramer et al., 2007; Li et al., 2007; Shan et al., 2007; Zhang et al., 2007) . All three effectors specifically inactivate their host MAPK pathways by removing the phosphate from the phosphothreonine in the pT-X-pY motif of phospho-MAPKs (p-MAPKs). Inhibition of MAPK signaling by OspF attenuates the recruitment of polymorphonuclear leukocytes to Shigella infection sites by suppressing the activation of a portion of NF-kB-responsive genes in mice (Arbibe et al., 2007) . Similarly, inactivation of the plant MAPKs by HopAI1 results in transcriptional downregulation of pathogen-associated molecular pattern (PAMP)-response genes as well as a compromised cell wall defense in Arabidopsis .
To reveal the mechanism underlying inactivation of MAPKs by the OspF family of effectors, we took advantage of mass spectrometry approaches and observed a mass loss of 98 dalton on the phosphothreonine in the pT-X-pY motif after modification by OspF, SpvC, or HopAI1 Zhang et al., 2007) . Based on these data, we concluded that the OspF family of effectors acts as phosphothreonine lyases Zhang et al., 2007) . The enzyme carries out a b elimination reaction to irreversibly remove the phosphate moiety from the phosphothreonine in p-MAPKs. Further biochemical analysis demonstrated that OspF and SpvC are specific for dualphosphorylated MAPKs with the highest activity toward p-p38 but negligible activity toward p-JNK. The phosphothreonine lyase activity of the OspF family of effectors is unique in that it represents the only known enzyme capable of carrying out b elimination of phosphoserine or phosphothreonine in protein substrates.
b elimination of phosphoserine or phosphothreonine is usually achieved by strong alkali action. For instance, 0.1 mol/L of sodium hydroxide is often used to eliminate phosphate groups from phosphoserine/phosphothreonine in phosphoproteomic analysis. This indicates that a strong base is required to abstract the a proton, due to its high pKa, for b elimination to occur. It is conceivable that such a reaction would be a difficult task for biological enzymes without assistance of any cofactors. Indeed, enzyme-catalyzed cleavage of C-O bonds through b elimination usually employs a covalent catalysis route and requires redox-active cofactors. Many such enzymes are pyridoxal-5 0 -phosphate (PLP)-dependent enzymes. For example, threonine synthase from bacteria and plants catalyzes an elimination reaction on O-phosphohomoserine, which generates a b, g unsaturated intermediate that is subsequently hydrated into threonine (Garrido-Franco et al., 2002) . A Schiff base adduct is formed between PLP and the a amine group of the substrate. The Schiff base has a strong electron-withdrawing power that renders the a proton amenable for base abstraction and further allows the catalysis to proceed. A similar mechanism is used by an 8 kDa 5
0 -deoxyribose phosphate lyase domain present in bacterial endonuclease III and several eukaryotic DNA polymerases that catalyze b elimination of a DNA-linked phosphate at abasic sites of damaged DNA (Bebenek et al., 2001; Garcia-Diaz et al., 2005; Pelletier et al., 1996) . In contrast, the OspF family of phosphothreonine lyses does not require any cofactors or metals for catalysis. The enzymatic mechanism of the MAPK phosphothreonine lyase activity of the OspF family is an interesting open question.
In this study, we determined crystal structures of SpvC and its complex with a phosphopeptide substrate. The phosphothreonine lyase adopts a unique fold of a/b type that resembles a cupped hand with a highly positivecharged active center on the concave side. The disordered N terminus of the enzyme mimics the host MAPK docking interactions by using a canonical D motif for specific recognition of MAPK substrates. In the SpvC/phosphopeptide complex structure, recognition of the phosphotyrosine and the phosphate of the phosphothreonine by the enzyme appears to play a critical role in positioning the reaction sites of the phosphothreonine into the enzyme catalytic site. Conformational changes of the pT-X-pY motif in p-MAPK upon binding to SpvC explain the differential activity of the enzyme toward different MAPK substrates and further suggest that p38 is likely the preferred target during bacterial infection. Based on the enzyme-substrate complex structure and extensive kinetic analysis, we propose an enzymatic mechanism for the phosphothreonine lyase-catalyzed b elimination reaction that involves K136 as a base to abstract the a proton and possibly H106 as an acid to facilitate cleavage of the Cb-OP bond.
RESULTS
Evidence for the Ca = Cb Bond in OspF/SpvCCatalyzed Reaction Product of Erk2 Arbibe et al. recently reported that OspF functions as a phosphatase to hydrolyze phosphates from p-MAPKs (Arbibe et al., 2007) . This is in contrast to our proposed phosphothreonine lyase activity of the OspF family of effectors. The reaction catalyzed by phosphatases generates a free hydroxyl group, whereas our proposed reaction will convert the phosphothreonine into an unnatural amino acid called b-methyldehydroalanine (dehydroalanine for phosphoserine) that contains an unsaturated Ca = Cb bond ( Figure 1A) . Two analytic biochemical approaches were employed to test the presence of the deduced b-methyldehydroalanine residue in Erk2 after reaction with OspF or SpvC. First, we incubated the synthetic Erk2 phosphopeptide (DHTGFL-pT-E-pY-VATR) with OspF and subjected the peptide product to further reaction with cysteamine (HSCH 2 CH 2 NH 2 ) in an alkali solution of pH 13. All the peptides were analyzed by mass spectrometry. Cysteamine is widely used to convert dehydroalanine/b-methyldehydroalanine into (S)-aminoethylcysteine or b-methyl-(S)-aminoethylcysteine, respectively, through Michael addition ( Figure 1A ) (Knight et al., 2003) . As shown in Figure 1B , a mass loss of 98 dalton from the Erk2 phosphopeptide was observed as a result of OspF treatment, and an additional mass of 77 dalton was regained after subsequent incubation with cysteamine. Results of tandem mass spectrometry analysis indicate that the 77 dalton mass increase occurred on the ''threonine'' residue ( Figure 1C) , consistent with the hypothesized addition reaction of the unsaturated Ca = Cb bond with cysteamine. Second, 1 H-NMR spectroscopy was used for structural characterization of the phosphothreonine lyase-treated phosphopeptide. We chose SpvC as the enzyme and the phosphopeptide from p38 as the substrate because reaction of this pair goes most exhaustively . A new quartet signal around 6.6 ppm emerges in the downfield region (aromatic and vinyl proton signal region, 6.0-8.0 ppm) of the 1 H-NMR spectrum of SpvC-reacted peptide compared with that of the control peptide ( Figure 1D ). The chemical shift and multiplicity of the new signal corresponds to the vinyl proton signal of b-methyldehydroalanine as previously reported (Kuipers et al., 1992) . These results provide direct evidence for the presence of Ca = Cb structure in OspF/ SpvC-processed phosphothreonine in Erk2 and substantiate the proposed phosphothreonine lyase activity of the OspF family of effectors.
Structures of SpvC and Its Complex with a Phosphopeptide Substrate
SpvC from Salmonella shares greater than 80% sequence similarity with OspF. SpvC exhibits similar substrate specificities, but better kinetic properties, compared with OspF . We determined the crystal structure of SpvC by single-wavelength anomalous diffraction (Se-SAD) at 2.3 Å resolution ( Figure 2A and Figure S1A , available online). The structure of an inactive mutant enzyme (SpvC K136A) in complex with a dual-phosphorylated peptide substrate was also solved at the resolution of 2.0 Å by molecular replacement (Figures 2B and 2C and Figure S1B) . Details of the crystallographic analysis are listed in Table 1 . Both structures contain one SpvC molecule in an asymmetric unit. The final model of the native structure contains residues 28-241 and misses residues 1-27, 66-67, 95, and 218-225 due to the lack of electron density. Two regions (residues 1-26 and 95-98) are disordered in the structure of the SpvC/phosphopeptide complex. SpvC adopts a compact a/b fold that contains nine a helices (a1-a9) and seven b strands (b1-b7) (Figure 2A ). The whole structure is shaped like a cupped hand. The seven b strands constitute an integrated antiparallel b sheet, which forms a curving plane on the concave side. The nine a helices are organized underneath and at the side of the central b sheet to form the convex surface. The three helices (a3, a5, and a7) at the bottom interact with the upper five b strands (b2, b3, b5, b6, and b4) through hydrophobic interactions that help to stabilize the curving plane. The N-terminal two helices (a1 and a2, residues 28-45) extend from the left side to the right to associate with a7 and a9 mainly through side-chain hydrophobic contacts. The long loop L1 (residues 46-59) linking a2 and a3 resides at the bottom of the molecule and interacts with a5 and a7 strongly. Loop L1, in combination with a1, a2, and a3, makes the whole structure compact. The five b strands (b2, b3, b5, b6, and b4), together with a6 and linking loops, form an open groove of about 30 Å in length, 7 Å in depth, and 20 Å in width at the concave side of the molecule. The molecular surface of SpvC is distinguished by its electrostatic distribution. The concave surface of the molecule is mainly positively charged, whereas the convexity is largely negatively charged ( Figure S1A ). The open groove is highly positive and readily accommodates the substrate with two negatively charged phosphates, as observed in the structure of the enzyme-substrate complex ( Figure S1B , see below). SpvC shows no structural similarity with any known phospholyase. No similar structures were retrieved from the DALI as well as the SSM server with the SpvC structure as the bait (Holm and Sander, 1993; Krissinel and Henrick, 2004) . These suggest a unique three-dimensional fold adopted by the OspF family of phosphothreonine lyases from pathogenic bacteria.
We used the SpvC K136A mutant and a 13 residue Erk5 phosphopeptide ( 213 EHQYFM-pT-E-pY-VATR 225 ) to obtain crystals of enzyme-substrate complex. We previously demonstrated that the OspF K134A mutant (equivalent to K136 in SpvC) is completely inactive by using both p-Erk2 and the Erk2 phosphopeptide as substrates . The Erk5 phosphopeptide is highly similar to the Erk2 phosphopeptide (DHTGFL-pT-E-pY-VATR) with only two nonhomologous residues. Compared with the Erk2 phosphopeptide, the Erk5 peptide gives a slightly lower K m (79.0 ± 7.5 mM versus 95.8 ± 2.4 mM) but a much lower k cat value (0.26 ± 0.01 S À1 versus 0.70 ± 0.04 S À1 ) in the OspF phosphothreonine lyase assay.
Nine residues ( 215 QYFM-pT-E-pY-VA 223 ) from the 13-mer (A) Stereoview of the overall structure of the native SpvC. The structure of SpvC shown in cartoon is shaped like a cupped hand. The picture is viewed from the side of the concave face. Secondary structure elements are numbered from the N terminus to the C terminus. All b strands are shown in green. The helices a1 (residues 28-36) and a2 (residues 37-45) and the loop L1 (residues 46-59) are in orange. Other helices (a3-a9) and loops are colored in blue and salmon pink, respectively. The dotted lines denote the disordered loops.
(B) Stereoview of the structure of SpvC K136A/phosphopeptide complex. The structure of SpvC K136A is shown as a cartoon in gray. Secondary structure elements that contribute to interactions with the phosphopeptide are marked. The Erk5 phosphopeptide ( 215 QYFM-pT-E-pY-VA 223 ) is in stick representation in yellow except that the phosphate sticks are in red. Blue labels mark the N and C termini of the peptide as well as the two phospho-amino acid.
(C) Stereoview of the sigma-A weighted 2F o À F c omit electron density map (contoured at 1.0 s) of the phosphopeptide in the complex structure.
Residues are in stick and marked with blue labels. The orientation is similar to that the peptide shown in (B). Only the main chain of V222 is shown due to the lack of density of its side chain.
phosphopeptide were identified based on electron density in the complex ( Figures 2B and 2C ). The substrate peptide adopts an oblique and open ''U'' shape and lies in the groove on the concave side of SpvC. The middle three residues (pT-E-pY) constitute the base of the ''U'' and are located at the bottom of the positively charged groove ( Figure 2B and Figure S1B ). The N-terminal four residues ( 215 QYFM 218 ) project outward into the space between the loop L4 and L9 and interact with L4 through main-chain hydrogen bond contacts. The C-terminal two residues (V222 and A223) of the peptide extend upward into the solvent, with V222 contacting the top of b5 through a main-side chain hydrogen bond.
Substrate Recognition by the Disordered N Terminus Mimics the Host MAPK Docking Interaction
The N-terminal 26 residues are disordered in both the native SpvC structure and its complex with the peptide substrate (Figures 2A and 2B ). This suggests that the N-terminal region of the enzyme is not required for peptide substrate binding. Detailed examination of the N-terminal sequence of the OspF family of effectors led to identification of a canonical D motif in SpvC, OspF, and VirA from Chromobacterium ( Figure 3A ). The D motif docking interaction was well established for the majority of MAPK substrates, activators, and regulators to specifically recognize MAPKs (Tanoue et al., 2002) . The D motif contains the consensus sequence (K/R) 1-2 -(X) 2-6 -Ø A -X-Ø B (where Ø A and Ø B are hydrophobic residues) (Zhou et al., 2006) . The basic residue(s) in the D motif binds to an acid patch comprised of two aspartic residues in MAPKs (D316 and D319 in Erk2); Ø A and Ø B make Van der Waals contacts with several hydrophobic residues in a hydrophobic docking groove adjacent to the acid patch in MAPKs (Zhou et al., 2006) . We then tested whether the putative D motif in the N terminus of OspF is responsible and sufficient for the phosphothreonine lyase to recognize Erk2 substrate. As shown in Figure S2 , recombinant OspF mutant with deletion of Additional allowed regions (%) 7.9 7.2 R merge = S hkl S j jI j (hkl) À < I(hkl) > j / S hkl S j < I(hkl) >, where I j (hkl) and < I(hkl) > are the intensity of measurement j and the mean intensity for the reflection with indices hkl, respectively. R work = S hkl jjF obs (hkl)j À jF calc (hkl)jj / S hkl jF obs j, R free is calculated with 5% of the total number of reflections for SeMet-WT and 10% for K136A-phosphopeptide (Erk5). I/s(I) is the ratio of the mean intensity to the mean standard deviation of intensity. a The data for the highest resolution shell are shown in parentheses.
the N-terminal 24 residues did not copurify with Erk2 on a Superdex gel filtration column in vitro. The truncation mutant also failed to coimmunoprecipitate with Erk2 when expressed in mammalian cells ( Figure 3B ). D motifs from several MAPK-binding proteins have been cocrystallized with MAPKs, suggesting that it is sufficient for MAPK binding (Chang et al., 2002; Farooq et al., 2001; Heo et al., 2004; Zhou et al., 2006) . Similarly, GST fused with only the N-terminal 26 residues of OspF that contain the presumed D motif efficiently pulled down Erk2 in mammalian cells, as shown in Figure 3C . Furthermore, mutation of two hydrophobic residues (L8 and L10) in the D motif into alanine almost completely abrogated the interaction between OspF and Erk2 in the immunoprecipitation assay ( Figure 3B ). In contrast, substitution of D316 and D319 with asparagine in Erk2 only slightly affected its binding to OspF, although it abolished the interaction between Erk2 and Mkp3 (Figure 3D) . These data suggest that hydrophobic interactions play the major role for the MAPK-docking D motif in OspF, consistent with the previously observed heterogeneity for a subset of D motifs (Zhou et al., 2006) . Thus, the phosphothreonine lyase appears to mimic host proteins and employs a canonical D motif in its N terminus for MAPK substrate docking.
Importance of Phosphotyrosine and Phosphothreonine Binding for Specific Substrate Recognition by SpvC
The OspF family of phosphothreonine lyases reacts with the dual-phosphorylated (pT-X-pY) MAPK substrates. In the enzyme-substrate complex, binding between the substrate peptide and SpvC occurs at two major loci: the phosphotyrosine (pY221) and the phosphothreonine (pT219). As shown in Figure 4A and Figure S1B , pY221 is located within a positively charged cleft formed by side chains of K134, K160, and F100 from SpvC. Two hydrogen bonds were observed between two of the phosphate oxygen atoms of pY221 and 3 amines of K134 and K160 in SpvC. The aromatic ring of F100 from L5 in SpvC forms a strong p-stacking interaction with that of pY221 in the peptide. The side chain of E215 makes a hydrogen bond with the amide of pY221. Interactions with pY221 are also accompanied by an additional hydrogen bond between the 3 amine of K134 and the carbonyl oxygen of V222 in the peptide. The interactions between SpvC and pY221 in the substrate are essential for efficient substrate recognition. Loss of the phosphate on the tyrosine decreases the binding affinity of the peptide to the enzyme by about 3-fold 
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Mechanisms of the MAPK Phosphothreonine Lyase . Similarly, recombinant SpvC K160A mutant shows a greater than 5-fold increased K m value, and the F100L mutant is largely inactive in the SpvC phosphothreonine lyase assay (Table 2 ). In contrast, the SpvC K134R mutant remains fully active and the activity of K134A mutant only decreases by about 2-fold ( Table 2 ), suggesting that the hydrogen bonding contact made by K160 and the p-stacking interaction between F100 and pY221 play the major role in phosphotyrosine binding by SpvC. Part of the phosphate is exposed to the solvent ( Figures 4A and 2B) , as accommodation of a phosphate by two lysines is not extensive and relatively weak. This is likely beneficial to dissociation of the peptide from the enzyme upon completion of the reaction. Consistent with this idea, the K160R mutation reduces the catalytic activity to half of the native enzyme without affecting the K m parameter (Table 2) .
pT219 is located at the center of the open groove in the SpvC structure. The phosphate is deeply inserted into a highly positively charged cavity and almost completely shielded from the solvent ( Figure 2B and Figure S1B ). Three arginines, including R148, R213, and R220, as well as K104 from SpvC make strong interactions of seven ionic pairs or hydrogen bonds with the three phosphate oxygen atoms ( Figure 4B ). These interactions firmly lock the position of pT219 into the potential catalytic site in the enzyme (see below), which allows the subsequent enzymatic reaction to occur on the threonine. Mutation of either of the basic residues (R148Q, R213Q, R220Q, and K104R) in SpvC resulted in enzymes with significantly The reaction was carried out in a bicine buffer (25 mM [pH 8.5]) at 22 C. ND means the activity is too low and kinetic parameters are not determined.
reduced phosphothreonine lyase activity (Table 2) . Contacts made by SpvC with other atoms of pT219 are discussed later, because they are likely directly involved in catalysis. Taken together, the two phosphate residues in the substrate peptide play critical roles in its recognition by SpvC. Binding of pY221 possibly facilitates the recognition of pT219 and its further placement into the active site of the enzyme.
Binding of the phosphopeptide substrate is accompanied by conformational changes of SpvC, mainly at three loci, as shown in Figure S3A . In the native structure, the middle region of L12 (S218-M225) is disordered. In the structure of the enzyme-substrate complex, all the residues of L12 have clearly visible electron density showing a definite conformation. L12 moves into the interior of the open groove to allow R220 in the loop to contact the phosphate of pT219 in the substrate ( Figure S3B ). The conformation of the loop is stabilized by hydrogen bonds between R213 and S218 as well as between G219 and Q226 ( Figure S3B ). The second conformational change occurs at the a6 and L9 region. In the structure of the enzyme-substrate complex, R148 of L9 moves by 7.2 Å to contact the phosphate of pT219 in the substrate. This movement results in a conversion of the eight-resdiue a6 into a 3 10 helix and an extension of L9 in length (Figure S3C) . Lastly, L4 also moves toward the inside of the groove and contributes to high-affinity substrate binding through a main-chain hydrogen bond ( Figure S3D ).
Conformational Flexibility of pT-X-pY Correlates with Catalytic Efficiency
MAPKs are activated by dual phosphorylation of the T-X-Y motif in the activation loop. The phosphate on the tyrosine is largely exposed to the solvent, as demonstrated in both p-Erk2 and p-p38g structures (Bellon et al., 1999; Canagarajah et al., 1997) . This structural feature is permissive for sufficient recognition of the phosphotyrosine by the OspF family of phosphothreonine lyases. In p-MAPKs, the phosphate on the threonine residue is ligated by three conserved arginines through ionic interactions or hydrogen bonds (Bellon et al., 1999; Canagarajah et al., 1997) , as also illustrated in Figure 5A . In the p-p38g structure, an additional lysine participates in interactions with the phosphate moiety. In this regard, accommodation of the phosphothreonine by an arginine-rich pocket appears to be similar between p-MAPKs and p-MAPK peptide bound to the pathogenic phosphothreonine lyase ( Figure 5A ).
The conformation of the pT-X-pY motif and presentation of the two phosphates are conserved in p-Erk2 and p-p38g (Bellon et al., 1999; Canagarajah et al., 1997) . The phosphate on the threonine projects toward the inside of the kinase and locks the kinase in an active conformation. We superimposed the Erk5 phosphopeptide in the SpvC complex structure with equivalent regions from p-Erk2 and p-p38g using the phosphotyrosine and its C-terminal valine as the reference. As shown in Figures  5A and 5B, a drastic conformational change of residues N-terminal to the phosphotyrosine was observed in the SpvC complex structure. Upon binding of pY221 to SpvC, the adjacent E220 (X in pT-X-pY) rotates around backbone atoms by about 135 and further moves by 3.3 Å (Ca of E220 relative to pY221) away from the kinase ( Figure 5B ). This further leads to the movement of pT219 by 3.5 Å , which pulls its phosphate out of the arginine pocket in the kinase and inserts it into that in SpvC ( Figure 5B) . As a consequence, release of the phosphothreonine from binding to the kinase itself will possibly reverse the conformation of the kinase into an inactive 
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Mechanisms of the MAPK Phosphothreonine Lyase state. Meanwhile, the conformational change of pT-X-pY in p-MAPKs upon binding to SpvC will prime the phosphothreonine for b elimination by the phosphothreonine lyase activity of SpvC.
We and others have previously demonstrated that OspF has the highest enzymatic activity toward p-p38 followed by p-Erk2 but is largely inactive with p-JNK as the substrate ( Figure 5C ) (Arbibe et al., 2007; Li et al., 2007) . The three kinases differ at the X residue in the T-X-Y motif with Pro in JNK, Glu in Erk2, and Gly in p38. Owing to the rigidity of the proline backbone and the flexibility of glycine, the aforementioned conformational change of pT-X-pY well explains the differential activity of OspF toward the three different MAPKs. Consistent with this hypothesis, substitution of proline with glycine in the JNK phosphopeptide turned the peptide into a much better substrate for OspF ( Figure 5C ). Reciprocally, mutation of glycine into proline in the p38 phosphopeptide resulted in an increase of the K m value by more than 10-fold (Figure 5C) . Therefore, the conformational flexibility of the pT-X-pY sequence in the substrate, dictated by the nature of the X residue, largely determines the catalytic efficiency when the substrate is subjected to reaction with the OspF family of phosphothreonine lyase. The results further suggest that p38 is likely the preferred host target for OspF and SpvC in the physiological context, in agreement with the fact that we only observed ''dephosphorylation'' of p38 by OspF in the Shigella infection assay .
pH-Rate Profile for SpvC
We previously identified three invariant residues, including K102, H104, and K134, that are essential for the catalytic activity of OspF. The equivalent residues (K104, H106, and A[K]136) in the SpvC K136A/phosphopeptide complex structure, together with T156 and Y158, sit at the bottom of the groove and their side chains accommodate the phosphothreonine ( Figures 2B and 6A ). These residues likely directly or indirectly participate in catalysis and form a potential catalytic center of the enzyme. Superimposition of the native structure and the complex revealed little geometric alteration in the positions of these residues (rmsd 0.287 Å ) except for the mutated K136 ( Figure 6A ). We then modeled K136 of the native structure into the complex structure for further analysis ( Figure 6B ).
To gain insights into the catalytic mechanism employed by the OspF family of phosphothreonine lyase, we measured the pH dependence of SpvC enzymatic activity with the Erk2 phosphopeptide substrate. The wild-type enzyme displays a bell-shaped pH-rate profile for k cat /K m , with the pH optimum of about 8.5 ( Figure 6C, upper panel) . Fitting the data to Equation 1 (see Experimental Procedures) yields one apparent pKa of 7.9 for the acidic group that is deprotonated and the other apparent pKa of 9.4 for the basic group that is protonated at the optimal pH of 8.5. We also determined the pH-rate profiles for Y158F and H106K mutant enzymes that retain enough activities for kinetic analysis. The profile for Y158F mutant displays a shift of the acidic limb of the bell curve to higher pH (apparent pKa, from 7.9 to 8.4), whereas pKa of the basic limb (9.5) remains similar to that of the wild-type enzyme (9.4) ( Figure 6C , middle panel). In the SpvC complex structure, we noted that K136 is hydrogen bonded to Y158 as the hydrogen donor ( Figure 6B ). This suggests a possibility that K136 is the acidic group with pKa of 7.9. The pHrate profile for the SpvC H106K mutant ( Figure 6C , lower panel) gives a similar k cat //K m profile at the acidic limb to that of the wild-type enzyme, but its k cat /K m value becomes independent of pH from 8.5 to 9.75 (the highest pH we can assay). Due to the loss of the basic limb, we fitted the data to Equation 2 and obtained a single apparent pKa of 8.1 for the acidic group, close to that observed for the wild-type enzyme. This result suggests that H106 is a possible candidate residue for the basic group with pKa of 9.4. The k cat //K m pH-rate profile reports ionizable groups on the free enzyme or free substrate that are important for chemical catalysis or substrate binding (Cleland, 1982) . Together, the above analysis suggests the involvement of a base and an acid for SpvC-catalyzed phosphothreonine lyase reaction.
The decreasing k cat /K m value at the basic limb in the pHrate profile for the wild-type enzyme is largely due to the increasing K m value (Table S1 ), suggesting that pHdependent ionization of the basic group is responsible for the increased K m value at pH above 8.5. In the SpvC complex structure, the N3 of H106 forms a strong hydrogen bond (2.9 Å ) with the oxygen atom bonded to Cb as a hydrogen donor ( Figure 6B ). As H106 in SpvC is conserved in the OspF family of phosphothreonine lyases and both H106A and H106N mutant enzymes are largely inactive toward the phosphopeptide substrates (Table  2) , we then tested whether H106 plays an important role in phosphopeptide substrate binding. In contrast to the K136A mutant, both inactive mutants of H106A and H106N failed to bind to the biotin-labeled phosphopeptide substrate when immobilized onto the streptavidin beads ( Figure S4A ). The dissociation constant (K D ) between the Erk5 phosphopeptide substrate and the SpvC K136A mutant or the SpvC K136A/H106A double mutant was measured by using the isothermal titration calorimetry (ITC) method. The single mutant (K136A) binds to the peptide substrate with a K D of about 102 mM, whereas the additional mutation of H106 into alanine results in nondetectable binding on ITC ( Figure S4B ). Combined with our failure of cocrystallization of the H106A mutant and the same Erk5 phosphopeptide substrate, these data suggest that the hydrogen-bond contact between H106 and the oxygen atom on Cb in pT219 plays a critical role for a productive enzyme/substrate binding. This observation explains the increased K m value at pH above 8.5 (Table  S1 ). Histidine must be kept at the protonated state to serve as a hydrogen bond donor. Thus, one important factor might be another strong hydrogen bonding contact between the Nd of H106 and the carboxylate of D201 observed in the SpvC complex structure ( Figure 6B ). Histidine has two neutral tautomers that are protonated on either the Nd or the N3 atom. The strong hydrogen bond keeps the N3 of H106 in the protonated form by increasing its pKa. Similar phenomena have been noted in a number of other enzymes, such as phosphite dehydrogenase (Woodyer et al., 2005) .
A Potential Catalytic Mechanism
The OspF family of phosphothreonine lyase catalyzes a b elimination reaction on the phosphothreonine in p-MAPKs. Abstraction of the a proton by a catalytic base is required for b elimination to occur. The intact a proton is believed to have a high pKa (for a proton in a ketone, $18-20) and is usually refractory to abstraction by an active residue of an enzyme. Formation of a Schiff base intermediate is often employed in biological catalysis to lower the pKa of the a proton. However, the carbonyl oxygen is not amenable for Schiff base adduct formation due to the presence of the adjacent amide. Indeed, the carbonyl oxygen was not subjected to 18 O isotope exchange when the reaction was carried out in H 2 18 O (data not shown). In the SpvC complex structure, several hydrogen-bond interactions are present that could reduce the pKa of the a proton of pT219 ( Figure 6B ). The carbonyl oxygen of pT219 makes two contacts with the 3 amine of K104 and the hydroxyl group of Y158 as hydrogen-bond acceptors. The amide nitrogen adjacent to the carbonyl of pT219 is at a distance of 3.4 Å from the Nx atom of R220, and they are likely hydrogen bonded. These interactions, together with a deduced hydrogen bond between the modeled K136 and the carbonyl oxygen of M218, will decrease the pKa of the a proton of pT219 and facilitate its abstraction by a base ( Figure 6D) . Results of enzymatic assay of the K104R, Y158F, and R220Q mutants of SpvC appear to support the above analysis (Table 2) .
No metals and cofactors are required for the b elimination reaction catalyzed by OspF and SpvC. Indeed, the k cat pH-rate profile retains the acidic limb and shows a possible sigmoidal pH dependence (although level off cannot be reached at pH below 9.55) ( Figure S6 ), which indicates that at least a catalytic base provided by the enzyme is required for the reaction. Y158 and K136 are two possible candidate residues for the catalytic base. However, the Y158F mutant retains partial activity and its hydroxyl group is more than 4 Å away from the Ca. In contrast, the N3 of the modeled K136 is at a close distance of 2.7 Å from the Ca of pT219 ( Figure 6B ), and no other residues in the enzyme are found within 4.0 Å from the Ca of pT219 ( Figure S5 ). This suggests that K136, rather than Y158, is more likely the candidate residue for the catalytic base. Several lines of additional structural and biochemical evidences provide strong supports for the proposed role for K136. (1) K136 is absolutely conserved in the OspF family of phosphothreonine lyase. (2) The SpvC K136A mutant is completely inactive, and no product formation can be observed on mass spectrometry after prolonged incubation of the peptide with excessive amounts of enzyme. Interestingly, the K136R mutant retains some residual activities (>1000-fold decrease of the reaction velocity even when excessive amounts of substrates were used) ( Table 2) . A possible explanation is that arginine can also serve as the catalytic base; this has been observed in several other enzymes, including inosine 5 0 -monophosphate dehydrogenase, pectate/pectin lyases, and fumarate reductase and Laspartate oxidase (reviewed in Guillen Schlippe and Hedstrom, 2005) . (3) Chemical modification of the inactive K136C mutant by 2-bromoethylammonium bromide that generates a g-thia-lysine (a structural analog of lysine) in place of K136 partially restored the phosphothreonine lyase activity ( Figure S7 ). In contrast, modification of the same cysteine into S-carboxyamidomethylcysteine by iodide acetamide failed to restore the enzymatic activity ( Figure S7 ). The only difference between the two cysteine derivatives is that the amine in g-thia-lysine is replaced with an amide in S-carboxyamidomethylcysteine, suggesting the proposed base function of K136 in SpvC. (4) A deprotonated state is a prerequisite for lysine to act as a base. In the complex structure, K136 is hydrogen bonded to the carbonyl oxygen of M218 in the substrate in addition to Y158 in SpvC ( Figure 6B ). These contacts will help to maintain K136 in the deprotonated state. Consistently, K136 in the context of an intact SpvC molecule can react with the unsaturated Cb in dehydroalanine (Dha) in a 5-mer peptide (M-Dha-G-pY-V) (but insensitive to b-methyldehydroalanine) through 1, 4 nucleophilic addition reaction. In contrast, the same lysine fails to do so when it exists in an unstructured peptide form (data not shown). As nucleophilic attack by lysine requires its deprotonation, this result further supports the notion that K136 in SpvC is in the deprotonated state as well as the proposed role of the catalytic base.
Protonation of the oxygen atom on Cb by an acid, concurrent to or after base abstraction of the a proton, is essential for completion of a b elimination reaction. A possible candidate for the acid is the conserved H106 in SpvC in addition to its critical function for efficient substrate binding. The strongest support for this hypothesis comes from the structure that H106 is at the closest distance of 2.9 Å from the leaving oxygen atom ( Figure S5 ). The SpvC H106N mutant has a significantly attenuated substrate-binding affinity and almost completely loses phosphothreonine lyase activity, thus providing little information about its role in catalysis ( Table 2 ). The k cat pH-rate profile reports the ionizable group in the enzyme-substrate complex. The profile for wild-type SpvC fails to reveal a potential catalytic acid that could lose a proton prior to reaction at the highest pH assayed (9.55) ( Figure S6 ). This result argues against other possible candidate residues for the acid. Instead, these data are consistent with H106 as the hypothesized acid, because the histidine is expected to lose ionization due to the stable hydrogen bond with the oxygen atom on Cb upon binding to the substrate. Furthermore, the pH profile for the H106K mutant provides us an ideal means to dissect its contribution in chemical catalysis from substrate binding. At pH below 8.5, both H106 in the wild-type enzyme and K106 in the mutant are protonated and likely hydrogen bonded with the leaving oxygen atom. Indeed, both enzymes give a comparable K m value at pH equal to or lower than 8.5 as shown in Table S1 . In contrast, H106K only retains partial activity with 5-to 7-fold decreased k cat values compared with those of the wild-type enzyme (Table S1 ). The most likely explanation is that the introduced lysine has a higher pKa, which not only results in the loss of the pH-dependent substrate binding observed for the wildtype enzyme but also is less effective in donating the proton to the leaving oxygen. The above structural and kinetic analysis clearly favors the idea that H106 also provides a proton to the leaving oxygen atom upon abstraction of the a proton by K136 ( Figure 6D ). The observation that H106 also functions as an acid rather than solely as a cation to stabilize the transition state raises an additional possible catalytic route, in which the reaction is switched to general acid-mediated process at the low pH. However, direct evidences for acid-base catalyzed reaction are always very difficult to obtain and alternative interpretations often exist. For instance, a water molecule activated by other groups in SpvC could also serve as an acid in theory.
Collectively, our structural and enzymological analysis reveals important insights into the potential catalytic mechanism for the OspF family of phosphothreonine lyases. The invariant K136 is at the closest distance to the a proton and is a candidate catalytic a base to abstract the a proton and initiate the b elimination reaction. The conserved H106 forms a strong hydrogen bond with the leaving oxygen on Cb, which is critical for substrate binding. H106 likely also acts as an acid to protonate the leaving oxygen and facilitate cleavage of the Cb-OP bond in the phosphothreonine. The reaction converts the phosphothreonine in the MAPK substrates into a b-methyldehydroalanine, as illustrated in Figure 6D . Further demonstration of the altered pKa of H106 and K136 is necessary to verify and firmly conclude the roles of these two residues in catalysis.
DISCUSSION
Our data provide biochemical and structural evidences for specific recognition of the dual-phosphorylated MAPK substrates by the OspF family of phosphothreonine lyases. Our structural analysis also explains the enzyme's differential activities toward different MAPK substrates and further suggests that p38 is likely the in vivo substrate for OspF and SpvC during bacterial infection. A catalytic mechanism of acid-base mediated b elimination of phosphoserine/phosphothreonine by biological enzymes is derived from extensive biochemical and enzymatic analysis based on the enzyme-substrate complex structure.
Mechanistic Conservations between Animal and Plant Bacterial Pathogenesis
Innate immunity, initiated by receptor perception of pathogen-associated molecular pattern, serves as the first line of defense against attempted microbial invasion in both plant and animal systems (Akira et al., 2006) . Although significant divergences exist between the two immune systems, MAPK pathways are highly conserved and play important roles in host innate immunity for both animals and plants. Interestingly, pathogenic bacteria from different kingdoms have also recognized the importance as well as the conservation and divergence of the host MAPK pathways. The YopJ family of serine/threonine acetyltransferases that targets the host MAPK kinase is widely present in animal pathogens, including Yersinia and Salmonella, as well as plant pathogens of Xanthomonas and Ralstonia (Worby and Dixon, 2006) . Similarly, the OspF family of phosphothreonine lyases includes OspF from Shigella, SpvC from Salmonella, and HopAI1 from plant pathogen Pseudomonas syringae. All three effectors of the OspF family target the pT-X-pY motif conserved in MAPKs from both kingdoms. SpvC and OspF also take advantage of a conserved MAPK-docking motif (D motif) in mammals to achieve specific recognition of MAPK substrates. The absence of such a docking motif in HopAI1 is plausible, as the D motif/MAPK docking interactions have not been reported for plant MAPKs. Therefore, despite similarly targeting the dual phosphorylated T-X-Y motif in MAPKs, the phosphothreonine lyase from plant pathogen might have devised an alternative strategy to specifically recognize the plant MAPKs.
Implications for Catalytic Mechanism of Lantibiotic Synthetase
Lantibiotic synthetase is the critical enzyme in the biosynthesis of lantibiotics in lactic bacteria, and it is responsible for introducing b-methyldehydroalanine into the peptide antibiotics during their maturation process (Patton and van der Donk, 2005) . Mechanistic understanding of the enzyme function has important implications for the food industry as well as development of new antibiotics for medical applications. Recent studies suggest that the serine/threonine residue is phosphorylated prior to dehydration by lantibiotic synthetase (Chatterjee et al., 2005) . This indicates that lantibiotic synthetase is a bifunctional enzyme that harbors kinase activity and b elimination activity on phosphoserine/phosphothreonine. The b elimination reaction catalyzed by lantibiotic synthetase is essentially identical to that by the OspF family of phosphothreonine lyases. Similar to OspF, lantibiotic synthetase does not require cofactors like PLP for its lyase function. Due to the complications of dissecting two enzymatic activities as well as the lack of structural information, the catalytic mechanism for the lantibiotic synthetase-catalyzed b elimination reaction has not been defined. In view of our mechanistic studies of the OspF family of phosphothreonine lyases, it is not surprising that lantibiotic synthetase may employ a catalytic base to abstract the a proton and an acid to facilitate fission of the Cb-O bond in its peptide antibiotics substrate. An arginine/lysine-rich pocket might also be present to ligate the phosphate on the threonine/ serine. Recent preliminary mutagenesis studies identified several acidic and basic residues important for the b elimination activity of the enzyme (You and van der Donk, 2007) , which appears to be consistent with our speculation. A final answer to this question will require a detailed structural model of the enzyme.
b Elimination of Phosphoserine/ Phosphothreonine: A Possible Posttranslational Modification in Mammals The OspF family of phosphothreonine lyases converts phosphothreonine into b-methyldehydroalanine in pMAPKs, thereby irreversibly inactivating the kinase. An interesting question is whether a similar enzyme exists in eukaryotes and whether b elimination of phosphoserine/ phosphothreonine could represent a new type of eukaryotic posttranslational modification to regulate protein functions. Serine/threonine phosphorylation is a widely used regulatory mechanism in eukaryotes. The presence of such enzymes would provide another means to ''dephosphorylate'' target proteins, thereby counteracting their regulation by kinases. Different from protein phosphatases, ''dephosphorylation'' by the hypothetic phospholyase is permanent and irreversible. In addition, the conformational rigidity of the peptide backbone resulting from generation of the a, b unsaturated dehydro-amino acid (Humphrey and Chamberlin, 1997) might create gain-of-function effects on the modified target protein. The a, b unsaturated dehydro-amino acid is electrophilic and susceptible to nucleophilic attack by thiols or amines. Dehydroalanine can form crosslinks of lanthionine and lysinoalanine with side chains of cysteine and lysine, respectively. Indeed, these kinds of crosslinks are present in human lens (Linetsky et al., 2004) . Meanwhile, mass spectrometry analysis further identified crystallin in aging human lens as one of the dehydroalanine-containing proteins (Srivastava et al., 2004) . The most efficient way to generate dehydroalanine is through b elimination of a phosphoserine. Therefore, it is not surprising if phosphoserine or phosphothreonine lyases exist in eukaryotes and serve as posttranslational modification enzymes.
EXPERIMENTAL PROCEDURES
Plasmid, Antibodies, and Reagents The cDNAs and constructs for OspF, SpvC, Mkp3, and Erk2 have been described before . Truncation mutants were constructed by standard PCR cloning strategy. All the point mutation constructs were generated by the QuikChange Site-Directed Mutagenesis Kit (Stratagene). All the plasmids were verified by DNA sequencing. Epitope antibodies for GST, Myc, and Flag were purchased from Santa Cruz, Covance, and Sigma, respectively. Synthetic peptides were purchased from or made by Anaspec. All other chemicals were SigmaAldrich products unless noted.
Expression and Purification of Recombinant Proteins
Recombinant OspF and SpvC proteins for enzymatic assays were described previously . For crystallization, the SpvC cDNA was cloned into the pGEX-6p-2 vector (Amersham). Bl21 (DE3) strain (Novagen) harboring the wild-type or the K136A mutant construct was induced for 8 hr at 22 C in the presence of 0.4 mM isopropylb-D-thiogalactopyranoside (IPTG) after OD600 reached 0.6-0.8. The GST fusion protein was purified by the glutathione-Sepharose resin, and the GST tag was then removed by PreScission protease digestion. The protein was further purified by ion-exchange chromatography and subsequent gel filtration chromatography (Superdex 75, Amersham). Selenomethionine-labeled (Se-Met) SpvC was produced following the method of inhibiting the bacterial methionine metabolism pathway (Doublie, 1997) . Briefly, the transformed BL21 (DE3) cells were grown in M9 media at 37 C. When OD600 of the culture reached 0.6-0.8, solid amino acid supplements (100 mg/L Lys, Phe, Thr; and 50 mg/L Ile, Leu, Val, and Se-Met) were added to the culture. Fifteen minutes later, cells were induced by 0.4 mM IPTG at 22 C overnight. Purification of Se-Met protein was performed following the same procedure as that for the wild-type protein.
Crystallization and Data Collection
The purified native and Se-Met proteins were concentrated to 30 mg/ml in a buffer containing 50 mM Tris-HCL (pH 8.5) and 0.15 M NaCl. Crystals of the native protein appeared in 20% PEG 3350 and 0.2 M ammonium chloride within one night after setup of initial screening. Crystallization of Se-Met protein was further optimized by using microseeding method, and diffraction-quality crystals were finally obtained in10% PEG3350, 0.1 M HEPES (pH 7.5) and 0.1 M sodium succinate. To obtain crystals of SpvC K136A and peptide complex, the purified K136A mutant was concentrated to 80 mg/ml in a buffer containing 50 mM Tris-HCL (pH 7.4) and 0.15 M NaCl. The 13-mer dual-phosphorylated Erk5 peptide ( 213 EHQYFM-pT-E-pY-VATR 225 ) was dissolved in a buffer containing 50 mM Tris-HCL (pH 8.5) and 0.15 M NaCl to the concentration of 7.5 mM. Mixtures of the protein and peptide solution at the volume ratio of 1:3 were incubated at room temperature for 2 hr prior to crystallization. The crystal of the enzyme-substrate complex was obtained in 18% PEG3350, 0.1 M MES (pH 6.0), and 0.1 M potassium sodium tartrate. All crystallization experiments were performed by using the hanging drop vapor diffusion method at 20 C.
The anomalous diffraction data (Se-Peak) for the wild-type protein were collected on a single Se-Met crystal at Beijing Synchrotron Radiation Facility at the wavelength of 0.9794 Å at 95K and processed by HKL2000 (Otwinowski and Minor, 1997) . The diffraction data of the SpvC K136A/peptide complex crystal were collected at an in-house X-ray facility (Rigaku R-Axis IV 2+ Image Plate) and processed by Mosflm and Scala (CCP4, 1994) .
Structural Determination and Refinement
The wild-type native structure was determined by Se-SAD using the program SOLVE (Terwilliger and Berendzen, 1999) . Seven Se atoms were found in one asymmetric unit. Density modification and subsequent automated model building were completed in RESOLVE (Terwilliger, 2000; Terwilliger, 2003) , which provided a 70% complete model. The remaining residues of the model were manually built with Coot (Emsley and Cowtan, 2004) and O (Jones et al., 1991) . The structure was refined to 2.3 Å in CNS version 1.1 (Brunger et al., 1998) by using data of the Se-Met crystal. The complex structure was determined with PHASER program and refined in Refmac5.0. The quality of both models was checked with PROCHECK program (Laskowski et al., 1993) . The statistics of data collection and refinement are listed in Table 1 . All structural pictures were drawn in PyMOL (http://www. delanoscientific.com/).
Cell Culture, Immunoprecipitation, and In Vitro Binding Assay Mammalian cell culture, transfection, immunoblotting, and immunoprecipitation are essentially the same as described previously . For in vitro binding assay of OspF and Erk2, the purified His-Erk2 protein was first mixed with the wild-type OspF or the truncation mutant (OspFDN24) at the mass ratio of 1:1. The mixtures were incubated overnight followed by gel filtration chromatography on a Superdex 75 column (Amersham) in a buffer containing 50 mM Tris-HCL (pH 7.4) and 0.15 M NaCl.
Chemical Modification and NMR Characterization
For alkylation of SpvC mutant proteins, the SpvC-C2S, SpvC-C2S-K104C, and SpvC-C2S K136C mutants were each diluted to 1 mg/mL in a bicine buffer (50 mM bicine, 150 mM NaCl [pH 8.5]). The solutions were then brought to 50 mM 2-bromoethylammonium bromide (2-BEAB) by addition of freshly prepared 1 M 2-BEAB in the same buffer.
The reaction was incubated for 16-24 hr at 25 C to allow for alkylation of the cysteine residue in the mutant enzyme. Iodide acetamide modification was carried out in the dark for 90 min. The expected modification was confirmed by tandem mass spectrometry analysis (data not shown). For cysteamine addition reaction, the Erk2 phosphopeptide was treated with OspF in a HEPES buffer (20 mM HEPES, 150 mM NaCl [pH 7.4]) at 30 C, and the modified peptide was separated from the enzyme by Amicon Ultra-4 centrifugal filter (Millipore). The solution was adjusted to pH 13 by addition of NaOH and further supplemented with 50 mM cysteamine. After a 4 hr incubation at 30 C, the reaction was terminated by adding HCl to bring the pH to 7-9. Samples were then subjected to mass spectral analysis. Procedures for mass spectrometry analysis of the reacted peptide and chemical modifications of mutant enzymes were similar to those described previously .
All NMR experiments were performed on a Varian Unity Inova 600 MHz spectrometer (Varian Inc, Palo Alto, CA, USA). To assay the Ca = Cb bond in SpvC-treated p38 phosphopeptide, 2 mg of synthetic p38 phosphopeptide (HTDDEM-pT-G-pY-VATR) in a NH 4 HCO 3 buffer (50 mM [pH 8.0]) was incubated with 2.5 mg of SpvC protein at 30 C for 6 hr. Modified peptide was separated from the enzyme by Amicon Ultra-4 centrifugal filter (Millipore) and lyophilized. Samples were then dissolved in D 2 O and subjected to 1 H-NMR analysis. The unreacted p38 phosphopeptide was used as the control.
Kinetic Analysis
The phosphothreonine lyase activity of SpvC or its mutants was determined at 22 C by measuring the release of the inorganic phosphate from the synthetic MAPKs' phosphopeptide substrates as previously described 
Isothermal Titration Calorimetry
Binding of SpvC mutant proteins with the Erk5 phosphopeptide was measured by isothermal titration calorimetry (ITC) on a VP-ITC calorimeter (MicroCal) at 25 C. Protein samples were prepared in an ITC buffer containing 50 mM bicine (pH 8.5) and 150 mM NaCl, and the concentration was determined by using Bio-Rad DC protein assay kit with bovine serum albumin as the standard. The Erk5 phosphopeptide was dissolved in the ITC buffer to a concentration of 750 mM. All samples were degassed prior to titration. 1.4 ml of 80 mM protein sample was titrated by 250 ml of the peptide solution over 25 injections. The heat resulting from dilution of the peptide was measured by titrating the peptide into the ITC buffer. Data were analyzed with Origin 7.0 software (MicroCal.). The binding constant and other thermodynamic parameters were calculated by fitting the integrated titration data using one binding-site model. The data were used to derive the pH-rate curve shown in Figure 6C . Color denotation is the same as in (A). The points shown are experimentally determined k cat values for SpvC enzymatic activity at indicated pH. The data were not fitted because k cat values can not reach the level-off at pH higher than 9.55 and accurate data set can not be obtained.
Supplemental Data

Figure S7. Effects of Chemical Modifications of K136 and K104 of SpvC on its Enzymatic Activity
The phosphothreonine lyase assay was performed as described in Table 2 using the Erk2 phosphopeptide substrate. The kinetic parameters for indicated SpvC variants are listed.
ND means that the activity is too low and the kinetic parameters are not determined.
SpvC C2S denotes the mutant of SpvC, where the only two cysteine residues are replaced with serines. BrEA is the compound bromoethylammonium bromide that modifies the cysteine into γ-thia-lysine. IAA is iodoacetamide that derives cysteine into Scarboxyamidomethylcysteine. S-carboxyamidomethylcysteine is structurally similar to γ-thia-lysine except that an amide is in place of the amine.
